# Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

> **NCT07218211** · PHASE4 · RECRUITING · sponsor: **Duke University** · enrollment: 100 (estimated)

## Conditions studied

- HIV Prevention
- HIV Pre-exposure Prophylaxis
- HIV Prevention Program
- HIV Prevention and Care
- HIV Pre-exposure Prophylaxis Use

## Interventions

- **DRUG:** Lenacapavir long-acting

## Key facts

- **NCT ID:** NCT07218211
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-13
- **Primary completion:** 2027-01-05
- **Final completion:** 2028-01-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07218211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07218211, "Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07218211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*